You are here: Industry Insights > Merck

News List

Merck KGaA refines Western European life science production site network cphi-online
July 17, 2017
Company to invest €90 million and cut 200 jobs.
Merck awards €1.25 million to research projects through its 2017 Grant for Fertility Innovation (GFI worldpharmanews
July 06, 2017
Merck awards €1.25 million to research projects through its 2017 Grant for Fertility Innovation (GFI)
Merck awards €1.25 million to research projects through its 2017 Grant for Fertility Innovation (GFI worldpharmanews
July 06, 2017
Merck, a leading science and technology company, today announced its commitment to award €1.25 million to research projects in the field of fertility, supporting the advancement of medical science through the Grant for Fertility Innovation (GFI) in 2017.
Merck moves up sales rankings in vaccine industry projection fiercepharma
July 05, 2017
Last year, life science commercial intelligence firm Evaluate released a vaccine market projection stating that GlaxoSmithKline would top the industry by 2022, with Sanofi, Pfizer and Merck trailing in order.
CRT and Merck extend partnership to discover new cancer drugs pharmaceutical-technology
July 03, 2017
UK-based Cancer Research Technology (CRT) has extended its collaboration with US pharmaceutical company Merck to discover new cancer drugs targeting the Hippo pathway.
Merck’s CETP inhibitor lowers risk of cardiac events pharmatimes
June 30, 2017
Merck’s CETP inhibitor lowers risk of cardiac events
Merck's anacetrapib meets primary endpoint cphi-online
June 30, 2017
Company to consider whether to file new drug applications with the FDA and other regulatory agencies.
Merck & Co hit by GoldenEye ransomware pharmaphorum
June 29, 2017
The attack is also understood to struck the Ukrainian central bank, Russian oil giant Rosneft, UK advertising firm WPP and the US law firm DLA Piper.
Merck and Premier collaborate to enhance patient care at reduced cost pharmaceutical-technology
June 28, 2017
US-based pharmaceutical company Merck has expanded its collaboration with healthcare company Premier to jointly develop and test solutions that would help improve patient care and wellness while reducing healthcare costs.
Regulators finally back Merck KGaA oral MS drug pharmaphorum
June 27, 2017
A long-awaited oral multiple sclerosis drug from Merck KGaA was among a raft of medicines given the green light by Europe’s regulator on Friday.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page